Get started
Pdunuwila

CARA

Long
Cara Therapeutics, Inc. (NASDAQ:CARA)  
Pdunuwila  
NASDAQ:CARA   Cara Therapeutics, Inc.
4
0
Price has pulled back recently to demand level. Should resume uptrend from this level. Good risk/reward at this level

Entry: $16.90
Stop Loss: $16.39
Target 1: $18.50
Target 2: $22
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.